EUCTR2005-001259-39-GB进行中（未招募）1 期
An investigation into a novel clinical use of a single low dose of insulin in the prevention of excessive cutaneous scarring
West Herts NHS Trust0 个研究点目标入组 15 人开始时间: 2005年6月2日最近更新:
适应症
相关药物
试验速览
- 阶段
- 1 期
- 状态
- 进行中（未招募）
- 发起方
- 入组人数
- 15
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
入选标准
- •Heathly subjects having elective bilateral breast reduction surgery.
- •Ages 18 - 65.
- •Caucasian (to exclude racial differences in scarring).
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) no
- •F.1.3.1 Number of subjects for this age range
排除标准
- •Diabetes mellitus
- •Patients with a history of hypertrophic or keloid scarring
- •Smokers - impairs wound healing
- •Any systemic illness that could have a theoretical interaction with the insulin administered such as patients with renal or liver disease or endocrine tumours
研究者
相似试验
尚未招募
2 期
Management of heel paiCTRI/2019/06/019744All India Institute Of Ayurveda
招募中
不适用
Study on the clinical efficacy and mechanism of Sijun Wupi Decoction in the treatment of refractory ascites due to liver cirrhosis based on the spleen governing transportation and chemistryRefractory ascites due to liver cirrhosisITMCTR2200005701Affiliated Hospital of Traditional Chinese Medicine
已完成
1 期
A phase 1 clinical pharmacological study with a single oral dose of KAG-308JPRN-UMIN000011878Kaken Pharmaceutical Co., LTD60
进行中（未招募）
不适用
A novel approach to clinical practice by using a shared decision-making model to target cardiovascular risk: The YANKEES studyObesity, Hypertension, Cardiovascular DiseaseCirculatory SystemISRCTN61164781ew York State Department of Health600
已完成
不适用
Clinical investigation of the safety of the MediSieve Magnetic Haemofiltration System in healthy volunteers.blood poisoning1002766510004018SepsisNL-OMON51755MediSieve Limited6